#SolvonisTherapeutics (LSE:SVNS) CEO #AnthonyTennyson joined Proactive's #StephenGunnion to discuss positive bridging pharmacokinetic data from the SVN-002 programme and what it means for the company's strategy in alcohol use disorder. youtu.be/TiQD2MoC4y8
Solvonis reports positive SVN-002 bridging data; CEO outlines next steps
YouTube video by Proactive Investors
youtu.be
June 22, 2026 at 1:34 PM
#SolvonisTherapeutics (LSE:SVNS) CEO #AnthonyTennyson joined Proactive's #StephenGunnion to discuss positive bridging pharmacokinetic data from the SVN-002 programme and what it means for the company's strategy in alcohol use disorder. youtu.be/TiQD2MoC4y8